| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $0 | -100.0% |
| R&D Expense | $5.4M | -40.3% |
| SG&A Expense | $8.1M | -32.9% |
| Operating Income | -$13.5M | +13.9% |
| Income Tax | $0 | — |
| Net Income | -$17.1M | -21.5% |
| EPS (Basic) | -$1.42 | -10.9% |
| EPS (Diluted) | -$1.42 | -10.9% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Current Assets | $1.0M | -83.0% |
| Total Assets | $1.0M | -90.1% |
| Current Liabilities | $12.9M | +82.2% |
| Total Liabilities | $12.9M | +78.4% |
| Stockholders' Equity | -$12.0M | -516.3% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$11.6M | +28.6% |
| Investing Cash Flow | $0 | -100.0% |
| Financing Cash Flow | $6.3M | -25.0% |